|
Type
2 Diabetes and Obesity, Third Edition
K. Chapman-Novakofski, RD, LDN, PhD
| C255 |
10 CPEUs |
DISCONTINUED |
|
|
| C255E |
10 CPEUs |
DISCONTINUED |
|
|
|
Manual with 1 Reporting Form, 92 pgs.
This learning program will help you:
- recognize the role of adipose tissue in the development of obesity
and type 2 diabetes
- discover the role of obesity in the development of insulin resistance
- use endocrine changes to explain how medical nutrition therapy can
be successful in the prevention and treatment of obesity and type
2 diabetes
- diagnose obesity, pre-diabetes, and type 2 diabetes
- discuss the differences between methods of body fat assessments
- use medical nutrition guidelines to develop meal plans with modifications
of fat, protein, carbohydrate and calories
- explain the glycemic index and glycemic load
- describe dietary fat modification and its implications on obesity
and type 2 diabetes treatment
- recognize the importance of both aerobic and strength training in
the treatment of both obesity and type 2 diabetes
- explain the rationale and mechanism of medication used for the treatment
of obesity and type 2 diabetes
For more information and customer comments, click
here.
Approved/Accepted by CDR, NCBDE
For RDs/RDNs & DTRs/NDTRs for the Professional Development
Portfolio:
SUGGESTED Learning Need Codes:
2000, 2020, 2050, 2070, 2090, 2100, 2110, 3000, 3005, 3010, 3020, 3030,
3040, 3060, 3080, 4000, 4010, 4020, 4030, 4040, 4050, 4060, 5000, 5190,
5260, 5370
SUGGESTED Performance Indicators (PIs):
1.2.2, 8.1.1, 8.1.2, 8.1.5, 8.3.1, 9.3.5, 10.1.3, 10.2.1, 10.2.2, 10.2.24, Series 10.2.7-10.2.10, 10.4.2, 12.4.6
DON'T SEE your Performance Indicators or Code Listed here?
There are many Performance Indicators (PIs) that are applicable we can't list them all &
Per CDR you may use ANY PI or CODE as long as it relates to your Learning Plan.
For details click here.
Share with a friend and Save! Click here for important information about
sharing.
To order an ADDITIONAL Reporting Form click below:
| C255F |
10 CPEUs |
DISCONTINUED |
|
|
Type
2 Diabetes and Obesity, Third Edition
Karen Chapman-Novakofski, PhD, RDN, LDN
© 2014 Wolf Rinke Associates. All rights reserved for this
self-directed learning program. Reproduction in whole or part without
written permission from the publisher is prohibited.
CUSTOMER COMMENTS
Courtney Goff: "this course is exactly what I needed--up
to date, comprehensive, confidence boosting. I also always appreciate
the ease of ordering and timely delivery service."
Karen Coles: "The case studies were helpful, kept
my interest and applied knowledge."
Amelia Murphy Bell: "Course was practically oriented. Course was
peer reviewed."
OVERVIEW AND INSTRUCTIONS
Obesity and diabetes are both increasing in the U.S. population. Obesity is a strong predictor of type 2 diabetes, although everyone who is obese does not have diabetes. Indeed, it is estimated that up to 25% of overweight people do not develop type 2 diabetes, and many of those with pre-diabetes are not overweight (Garber, 2012). Nutrition therapy has been shown to have a significant impact on weight loss, glycemic control, hypertension, and lipid profiles in persons with diabetes. Effective nutrition therapy requires careful meal planning and food selection, and should be individualized to the person (Evert et al., 2013). Adherence to a meal plan or dietary recommendations has been reported to be low, with few adhering to all the dietary recommendations provided (Broadbent et al, 2011). Indeed, research has shown that people with diabetes have limited knowledge of how to apply nutrition information to meal plans (Herrejon et al., 2009). Patients with diabetes have also indicated that adherence to both oral medication and insulin regimens are higher than adherence to moderate dietary modifications (Broadbent et al., 2011). The goal of this CPE program is to provide the nutrition professional with an understanding of the pathology of these conditions. In addition, the nutrition professional will develop competency in designing strategies to prevent or treat obesity and type 2 diabetes.
Chapter 1 describes the normal physiology of tissues and systems involved in the non-obese, non-diabetic person as well as how these tissues and secretions change with obesity and insulin resistance. In Chapter 2, the theories of how obesity is involved in the development of type 2 diabetes are explained. The pathophysiology and diagnosis of pre-diabetes, type 2 diabetes, and obesity are included in Chapter 3. Medical Nutrition Therapy for type 2 diabetes and its application to obesity are the focus of Chapter 4. Modifications of fat, protein, and carbohydrate are described as well as the recommended distribution of the macronutrients. Information about sugar substitutes, fiber, and the glycemic index are also included. Exercise and physical activity are important considerations in both type 2 diabetes and obesity. The role of aerobic and strength training in these conditions is explored in Chapter 5. Equally important is knowledge of medications used to treat diabetes and obesity, which are included in Chapter 6. Clinical implications are highlighted in each chapter. A case study integrates the information from these six chapters and provides examples of diagnosis and treatment. Also included is a listing of additional sources for your continued learning as well as organizations that are resources for additional information or updates.
This pre-approved CPE self-study program is a Level 2 CPE program approved for 10 Continuing Professional Education Units (CPEUs), meaning that the reader has general knowledge of the literature and professional practice within the area covered. The focus of this CPE program is to enhance knowledge and application.
To get the most benefit from this CPE program, I suggest that you follow these four steps:
Step 1: Review the objectives for the program.
Step 2: Study each chapter. As you read, think of patients or clients from your own practice who fit the situation described.
Step 3: Assess what you have learned by completing the self-assessment instrument at the end of this program.
Step 4: Compare your answers to the answer key that has been provided. If you score at least 80% correct (40 questions), you are ready to transfer your answers to the CPE REPORTING FORM. If you scored less than 80% correct, re-read this program until you score at least 80% correct.
After you have successfully completed this CPE program, fill out the CPE REPORTING FORM and:
Submit on-line at www.easyCPEcredits.com,
Or fax to: (410) 531-9282,
Or mail to: Wolf Rinke Associates, 3801 Schuylkill Road, Spring City, PA 19475
We will e-mail your Certificate of Completion.
When you submit your CPE Reporting Form to us via www.easyCPEcredits.com, fax or mail, be sure to write your correct email address in the space provided on the CPE Reporting Form. If writing by hand, be sure to print your e-mail address clearly.
To ensure that our e-mails are delivered to your inbox (instead of your junk/spam folders), please add cpesupport@wolfrinke.com to your Address Book or Safe List of allowed email senders. Also, be sure to allow attachments from this email address.
Happy Learning!
Karen Chapman-Novakofski, PhD, RDN, LDN
OBJECTIVES
Upon completion of this accredited, self-directed learning program,
the nutrition professional should be able to:
- assess the role of adipose tissue in the development of obesity
and type 2 diabetes
- formulate three hypotheses that explain the role of obesity in the
development of insulin resistance
- interpret endocrine changes to explain how medical nutrition therapy
can be successful in the prevention and treatment of obesity and type
2 diabetes
- apply guidelines for the diagnosis of obesity, pre-diabetes, and
type 2 diabetes
- assess the effectiveness of different methods of body fat assessment
- apply medical nutrition guidelines to develop meal plans with modifications
of fat, protein, carbohydrate, and calories
- explain the glycemic index and glycemic load to patients and clients
- discuss dietary fat modification and its implications on obesity
and type 2 diabetes treatment with patients and clients
- evaluate the importance of aerobic and strength training in the
treatment of obesity and type 2 diabetes
- explain the rationale and mechanism of medication used for the treatment
of obesity and type 2 diabetes to patients and clients
TABLE OF CONTENTS
CHAPTER 1. NORMAL PHYSIOLOGY
Adipocytes
Adipose Tissue
Adipose Tissue Distribution
Endocrine Function
Pancreas
Insulin
Glucagon
Somatostatin
Pituitary gland
Growth hormone
Adrenal glands
Cortisol
Epinephrine and norepinephrine
Stomach and gastrointestinal tract
Ghrelin
Peptide YY3-36
Adipose tissue
Leptin
Adiponectin
Resistin
Tumor necrosis factor a
Plasminogen activator inhibitor-1
Clinical Implications
CHAPTER 2. OBESITY'S ROLE IN TYPE 2 DIABETES
Genetic Studies
Ectopic Lipid Accumulation
Activation of Unfolded Protein Response Pathway
Inflammatory Response
Clinical Implications
CHAPTER 3. PATHOPHYSIOLOGY, CLASSIFICATIONS, DIAGNOSIS AND SYMPTOMS
Pre-Diabetes
Type 2 Diabetes
Obesity
Body mass index
Waist circumference
Skinfold thicknesses
Measurements of body fat for research rather than clinical applications
Bioelectrical impedance analysis
Dual energy x-ray absorptiometry
Computed tomography
Magnetic resonance imaging
Clinical implications
CHAPTER 4. DIET AND THE TREATMENT OF TYPE 2 DIABETES AND OBESITY
Modification of Fat
Total fat
Saturated fat
Unsaturated fat
Omega-three fatty acids
Trans fatty acids
Modification of Protein
Modification of Carbohydrate
Total carbohydrates
Fructose
Whole grains and fiber
Glycemic response
Low calorie nutritive and nonnutritive sweeteners
Modification of Calories
Distribution of Macronutrients
Meal Planning Tools
The plate method
Pre-planned menus
The exchange system
Carbohydrate counting
Clinical Implications
CHAPTER 5. PHYSICAL ACTIVITY AND THE TREATMENT OF TYPE 2 DIABETES AND OBESITY
Aerobic Activity
Resistance Training or Strength Training
Recommendations
Clinical Implications
CHAPTER 6. MEDICATIONS AND THE TREATMENT OF TYPE 2
DIABETES AND OBESITY
Oral Medications for Treatment of Diabetes
Sulfonylureas
Glinides
Biguanides
Thiazolidinediones
Alpha-glucosidase inhibitors
Dipeptidyl peptidase inhibitors
Injectable Medications for Treatment of Diabetes
Insulin
Amylin analogs
Incretin mimetics
Oral Medications for Treatment of Obesity
Clinical Implications
CASE STUDIES
Case Study #1
Case Study #2
Case Study #3
REFERENCES
FOR YOUR CONTINUING LEARNING
LIST OF ABBREVIATIONS
GLOSSARY
RESOURCES
SELF-ASSESSMENT QUESTIONS
ANSWER KEY
EXPLANATION OF ANSWERS TO SELF-ASSESSMENT QUESTIONS
ABOUT THE AUTHOR
ABOUT WOLF RINKE ASSOCIATES, INC
ABOUT THE AUTHOR
Dr. Chapman-Novakofski earned her bachelor's degree from the University of Illinois at Urbana-Champaign, her master's degree from Eastern Illinois University, and her doctorate from the University of Illinois at Urbana-Champaign. She completed her dietetic internship at the University of Alabama in Birmingham, was a dietitian at the VA Medical Center in Danville, Illinois, for 11 years, and has been at the University of Illinois at Urbana-Champaign in the College of Medicine since 1983, and in the Department of Food Science and Human Nutrition and Division of Nutritional Sciences since 1991.
As a Professor, Dr. Chapman-Novakofski has more than 250 abstracts, proceedings, and journal publications, most addressing some aspect of geriatric nutrition. In addition to healthy aging, her research and publications address diabetes and nutrition education strategies for this age group. She has written the newsletter Diabetes Lifelines since 2000, which is posted and archived on the website http://www.urbanext.uiuc.edu/
diabetes/index.html in English and Spanish. She also maintains the Your Guide to Diet and Diabetes website at http://urbanext.illinois.edu/diabetes2/.
In 2004, Dr. Chapman-Novakofski was honored with two awards: the Mid-Career Award in Nutrition Education from the Society for Nutrition Education and the Innovative or Outstanding Team Program from Illinois Extension for their community-based diabetes education program. In 2006 Dr. Chapman-Novakofski received the Outstanding Research Paper Award from the American Dietetic Association Diabetes Care and Education Practice Group, and in 2008 she received the Abbott Award for Women's Health from the American Dietetic Association Foundation.
Return to the top of page
If you prefer to order by phone, mail
or fax click below
or click here to contact us with
other questions.
For information about our other products and
services return to the sidebar at the top of the page.
|
|
|
